Eramol (UK) Ltd

www.eramol.com www.linkedin.com/company/eramol/

Eramol was founded in the UK by Qualified Persons (QPs) with over 30 years’ industry experience and a shared vision to deliver what the market lacked – high-quality, end-to-end, bespoke clinical contract manufacturing, packaging and global distribution services.

At Eramol, we pride ourselves on adding value to our clients at every critical stage of their journey to a successful clinical study – from regulatory guidance, development services, manufacturing, to labelling and packaging, logistics and specialist supply chain services including UK & EU QP Release.

Eramol’s vertically integrated clinical services enables efficient turnaround for early phase development projects including import, manufacturing and packaging of psychedelics and other narcotics.

With manufacturing facilities in both the UK and Ireland and an established global distribution network, we deliver international clinical trial services that work smarter, more efficiently and more reliably for clients in a complex, fast-changing, post-pandemic world.

• Bespoke manufacturing, packaging & QP release of psychedelics/ Schedule 1 narcotics

• ‘Just in time’, ‘Fast Lane’ packaging & labelling

• API neat-fill capsule manufacturing for rapid early phase supply

• UK/EU importation & QP Release

• Formulation development & QC-testing

• Manufacturing (tablets, liquids and capsules)

• Primary/Secondary packaging & labelling

• Global distribution & logistics services

Peter Mollison Chief Executive Officer

+44 129 336 8080 peter@eramol.com